Blair William & CO Becton Dickinson & CO Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Blair William & CO holds 38,322 shares of BDX stock, worth $8.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

38,322

Previous 36,569 4.79%

Holding current value

$8.74 Million

Previous $8.55 Million 8.11%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$221.47 - $242.41 $388,236 - $424,944	1,753 Added 4.79%	38,322 $9.24 Million
Q2 2024 Aug 12, 2024	SELL	$225.07 - $246.17 $461,843 - $505,140	-2,052 Reduced 5.31%	36,569 $8.55 Million
Q1 2024 May 09, 2024	SELL	$233.45 - $247.73 $1.98 Million - $2.1 Million	-8,468 Reduced 17.98%	38,621 $9.56 Million
Q4 2023 Feb 12, 2024	SELL	$232.24 - $267.23 $1.53 Million - $1.76 Million	-6,576 Reduced 12.25%	47,089 $11.5 Million
Q3 2023 Nov 09, 2023	BUY	$254.9 - $283.59 $491,957 - $547,328	1,930 Added 3.73%	53,665 $13.9 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $430,532 - $479,167	1,806 Added 3.62%	51,735 $13.7 Million
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $1.02 Million - $1.15 Million	4,444 Added 9.77%	49,929 $12.4 Million
Q4 2022 Feb 10, 2023	SELL	$218.29 - $256.91 $407,110 - $479,137	-1,865 Reduced 3.94%	45,485 $11.6 Million
Q3 2022 Nov 09, 2022	BUY	$51.03 - $264.23 $7,450 - $38,577	146 Added 0.31%	47,350 $10.6 Million
Q2 2022 Aug 10, 2022	BUY	$234.74 - $275.42 $9,154 - $10,741	39 Added 0.08%	47,204 $11.6 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $162,751 - $180,680	-668 Reduced 1.4%	47,165 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $301,864 - $329,233	-1,312 Reduced 2.67%	47,833 $12 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $42,820 - $47,190	184 Added 0.38%	49,145 $12.1 Million
Q2 2021 Aug 12, 2021	SELL	$232.65 - $254.58 $1.92 Million - $2.1 Million	-8,257 Reduced 14.43%	48,961 $11.9 Million
Q1 2021 May 13, 2021	SELL	$232.09 - $256.88 $2.68 Million - $2.97 Million	-11,548 Reduced 16.79%	57,218 $13.9 Million
Q4 2020 Feb 09, 2021	SELL	$221.92 - $245.94 $1.76 Million - $1.95 Million	-7,946 Reduced 10.36%	68,766 $17.2 Million
Q3 2020 Nov 06, 2020	BUY	$215.77 - $276.76 $1.08 Million - $1.38 Million	4,984 Added 6.95%	76,712 $17.8 Million
Q2 2020 Aug 12, 2020	BUY	$219.9 - $263.41 $2.05 Million - $2.45 Million	9,316 Added 14.93%	71,728 $17.2 Million
Q1 2020 May 11, 2020	SELL	$195.69 - $279.01 $618,184 - $881,392	-3,159 Reduced 4.82%	62,412 $14.3 Million
Q4 2019 Feb 13, 2020	SELL	$236.45 - $266.82 $877,229 - $989,902	-3,710 Reduced 5.36%	65,571 $17.8 Million
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $803,110 - $891,926	-3,483 Reduced 4.79%	69,281 $17.5 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $1.2 Million - $1.35 Million	-5,504 Reduced 7.03%	72,764 $18.3 Million
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $262,507 - $316,168	1,274 Added 1.65%	78,268 $19.5 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $973,286 - $1.23 Million	4,754 Added 6.58%	76,994 $17.3 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $2.77 Million - $3.05 Million	11,901 Added 19.72%	72,240 $18.9 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $242,020 - $271,967	1,163 Added 1.97%	60,339 $14.5 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $161,286 - $188,611	785 Added 1.34%	59,176 $12.8 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $1.09 Million - $1.29 Million	5,775 Added 10.98%	58,391 $12.5 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $9.83 Million - $10.5 Million	52,616	52,616 $10.3 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account